The above results indicated that miR-133b, miR-206, and miR-542-3p are the NRF2-silencing-inducible miRNAs, and therefore, might be responsible for the dual inhibition of c-MET and EGFR in shNRF2 cancer cells. The gene discussed is NFE2L2; the disease is cancer.